These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1314242)

  • 21. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three year hospital experience with control of major obesity by VLCD in medically compromised individuals.
    Shapiro H; Weinkove C; Coxon A; Kreitzman S; Rodgers M
    Int J Obes; 1989; 13 Suppl 2():125-9. PubMed ID: 2613407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy and safety of dexfenfluramine treatment in obese adolescents].
    Małecka-Tendera E; Koehler B; Muchacka M; Wazowski R; Trzciakowska A
    Pediatr Pol; 1996 May; 71(5):431-6. PubMed ID: 8710426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of withdrawal and re-introduction of dexfenfluramine in the treatment of obesity.
    Ditschuneit HH; Flechtner-Mors M; Adler G
    Int J Obes Relat Metab Disord; 1996 Mar; 20(3):280-2. PubMed ID: 8653152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of diet, exercise and intermittent treatment of cimetidine on body weight and maintenance of weight loss. A 42 months follow-up study.
    Birketvedt GS; Thom E; Bernersen B; Florholmen J
    Med Sci Monit; 2000; 6(4):699-703. PubMed ID: 11208394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A; Breum L; Toubro S; Hein P; Quaade F
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of obesity with a very-low-calorie liquid-formula diet: an inpatient/outpatient comparison using skimmed-milk protein as the chief protein source.
    Howard AN; Grant A; Edwards O; Littlewood ER; McLean Baird I
    Int J Obes; 1978; 2(3):321-32. PubMed ID: 721370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G; Crepaldi G; Inelmen EM; Bruni R; Baggio B
    Clin Neuropharmacol; 1988; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects on lipid metabolism of weight reduction on lactovegetarian and mixed diet.
    Marniemi J; Seppänen A; Hakala P
    Int J Obes; 1990 Feb; 14(2):113-25. PubMed ID: 2111292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized evaluation of a low fat ad libitum carbohydrate diet for weight reduction.
    Schlundt DG; Hill JO; Pope-Cordle J; Arnold D; Virts KL; Katahn M
    Int J Obes Relat Metab Disord; 1993 Nov; 17(11):623-9. PubMed ID: 8281220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine and metabolic effects of dexfenfluramine in patients with android obesity.
    Ditschuneit HH; Flechtner-Mors M; Dolderer M; Fulda U; Ditschuneit H
    Horm Metab Res; 1993 Nov; 25(11):573-8. PubMed ID: 8288160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of sibutramine for the maintenance of weight loss. A randomized controlled clinical trial].
    Toubro S; Hansen DL; Hilsted JC; Porsborg PA; Astrup AV;
    Ugeskr Laeger; 2001 May; 163(21):2935-40. PubMed ID: 11402974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Different therapies in the treatment of obesity in hypertensive patients].
    Monego ET; Peixoto Mdo R; Jardim PC; Sousa AL; Braga VL; Moura MF
    Arq Bras Cardiol; 1996 Jun; 66(6):343-7. PubMed ID: 9035450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.
    Ryttig KR; Tellnes G; Haegh L; Bøe E; Fagerthun H
    Int J Obes; 1989; 13(2):165-71. PubMed ID: 2545640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptation to low calorie intake in obese mice: contribution of a metabolic component to diminished energy expenditures during and after weight loss.
    Dulloo AG; Calokatisa R
    Int J Obes; 1991 Jan; 15(1):7-16. PubMed ID: 2010261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.